The quantification of cancer medicines in Zambia
The quantification of cancer medicines in Zambia
Lived experiences of survival following cancer treatments
SABCS 2023: Latest breast cancer diagnostics guidelines
Relapsed refractory multiple myeloma
Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
Haemato-oncological Cancers
GI cancers
Breast Cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Cost-benefit analysis of new cancer medicines: The difficult choices of governments